CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 30,000 shares at $1.01 ($30,300)
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
Page 10 of 21 · 420 filings